Supriya Lifescience Ltd. (SUPRIYA) Share Price Rises 5.28% Today

Supriya Lifescience Ltd. rose to Rs 844.80 on 02 September 2026, up Rs 42.40 or 5.28% from the previous close of Rs 802.40. The stock traded between Rs 799.45 and Rs 848.55, opened at Rs 800.05, and recorded turnover of Rs 3.54 crore. Market capitalisation stood at Rs 6,457.94 crore.

The supplied data confirms a strong one-day move in Supriya Lifescience Ltd. Share Price, but it does not establish any company-specific trigger. That means the most useful way to read the rise is through price action, valuation and peer context rather than through an assumed catalyst.

Supriya Lifescience Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 844.8
Previous Close	Rs 802.4
Today's Move	Rs 42.4 (+5.28%)
Open	Rs 800.05
High	Rs 848.55
Low	Rs 799.45
Turnover	Rs 3.54 crore
Market Capitalisation	Rs 6,457.94 crore
Market Cap Category	Mid Cap

Supriya Lifescience Ltd. (SUPRIYA) rose to Rs 844.8 from the previous close of Rs 802.4, a move of Rs 42.4 or 5.28%. The stock opened at Rs 800.05, reached a high of Rs 848.55, recorded a low of Rs 799.45.

Supriya Lifescience Ltd. Share Price moved decisively above the previous close during the session. After opening at Rs 800.05 against the prior close of Rs 802.40, the stock touched a low of Rs 799.45 and then advanced to a high of Rs 848.55. The latest supplied price was Rs 844.80, leaving it near the top end of the intraday range.

That matters because the day’s move was not just a brief spike. The stock added Rs 42.40, or 5.28%, and held most of that gain into the latest quoted level. Turnover of Rs 3.54 crore indicates active trading interest, while the market value of Rs 6,457.94 crore provides the scale context for the move.

For readers tracking Supriya Lifescience Ltd. Share Price Today, the key takeaway is simple: this was a clear gain session with price strength sustained through most of the day’s range. The data supports attention on the move, but not a conclusion about why it happened beyond market trading itself.

Supriya Lifescience Ltd. (SUPRIYA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,457.94 crore
P/E Ratio	32.55x
P/B Ratio	5.29x
ROE	20.74%
ROCE	27.63%
EPS	Rs 24.65
Book Value Per Share	Rs 151.81
Dividend Yield	0.12%

Supriya Lifescience Ltd. (SUPRIYA) fundamental metrics show P/E 32.55x, P/B 5.29x, ROE 20.74%, ROCE 27.63%. These figures provide context only and are not a buy or sell signal.

Supriya Lifescience Ltd. has a market capitalisation of Rs 6457.94 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 32.55x, P/B at 5.29x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.74% and ROCE of 27.63%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 24.65, book value per share of Rs 151.81, dividend yield of 0.12%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.29x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	32.55x
Benchmark Median P/E	31.29x
Benchmark Average P/E	48.12x
Benchmark P/E Range	3.68x to 653.31x
Company P/B Ratio	5.29x
Benchmark Median P/B	2.88x
Company ROE	20.74%
Benchmark Median ROE	11.79%
Company ROCE	27.63%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 6,457.94 crore
Benchmark Median Market Cap	Rs 720.34 crore

Supriya Lifescience Ltd. (SUPRIYA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Supriya Lifescience Ltd. (SUPRIYA) has a P/E ratio of 32.55x, which is above the benchmark median of 31.29x, a difference of +4.03%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Supriya Lifescience Ltd. (SUPRIYA) has a ROE of 20.74%, which is above the benchmark median of 11.79%, a difference of +75.91%. Supriya Lifescience Ltd. (SUPRIYA) has a ROCE of 27.63%, which is above the benchmark median of 13.63%, a difference of +102.71%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,69,309.92	38.29	5.36	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,45,425.7	83.18	13.77	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,347.12	86.48	21.02	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,919.92	25.73	4.31	19.69	21.39
Cipla Ltd.	CIPLA	1,14,392.76	33.99	3.26	11.83	16

Supriya Lifescience Ltd. (SUPRIYA) has a P/E ratio of 32.55x compared with the displayed peer median of 38.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.74% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 27.63% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Supriya Lifescience Ltd. (SUPRIYA) has a market capitalisation of Rs 6,457.94 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Supriya Lifescience Ltd.

• The stock rose 5.28% to Rs 844.80 in one session.
• It traded near its intraday high of Rs 848.55 after opening at Rs 800.05.
• P/E at 32.55 is close to the industry median of 31.29.
• ROE of 20.74% and ROCE of 27.63% are above industry medians of 11.79% and 13.63%.
• Peer data shows strong ROCE despite a much smaller market capitalisation than large pharma names.

About Supriya Lifescience Ltd.

Supriya Lifescience Ltd. is listed in Healthcare under Pharmaceuticals & Drugs. Based on the supplied market data, the company currently carries a market capitalisation of Rs 6,457.94 crore. For market readers, the current story is less about scale leadership and more about how the company’s valuation and profitability profile compare with its industry and major peers.

Track Supriya Lifescience Ltd. Share Price on Univest

Use Supriya Lifescience Ltd. (SUPRIYA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can follow Supriya Lifescience Ltd. (SUPRIYA) live share-price page for price updates and key ratios, use the Univest top gainers screener for broader market movers, and visit Univest market blogs for related market coverage. For anyone monitoring Supriya Lifescience Ltd. Share Price after today’s rise, the useful framework is live price movement plus sector and peer comparison, not the one-day move alone.

Frequently Asked Questions

Why is Supriya Lifescience Ltd. Share Price rising today?

Ans. The supplied data shows Supriya Lifescience Ltd. Share Price up 5.28% at Rs 844.80 from the previous close of Rs 802.40. However, the dataset does not provide a company-specific reason for the move.

What is Supriya Lifescience Ltd. Share Price Today?

Ans. The latest supplied price is Rs 844.80. That is a gain of Rs 42.40 on the day, after the stock opened at Rs 800.05 and traded between Rs 799.45 and Rs 848.55.

How do the company’s valuation and profitability compare with the industry?

Ans. Supriya Lifescience Ltd. trades at P/E 32.55 versus the same-industry median of 31.29 and average of 48.12. Its P/B is 5.29 versus median 2.88 and average 4.35. ROE is 20.74% versus median 11.79% and average 11.21%, while ROCE is 27.63%.

How does Supriya Lifescience Ltd. compare with major pharma peers?

Ans. Compared with Sun Pharma, Divi's, Torrent Pharma, Zydus and Cipla, Supriya Lifescience Ltd. has a much smaller market cap at Rs 6,457.94 crore. Its P/E of 32.55 is lower than Sun Pharma, Divi's and Torrent Pharma, slightly below Cipla, and.